Sign In
Buy NOTV
$0.120
-0.140 (-53.96%)
At Close: Jun 03, 2026
Inotiv, Inc. (NOTV) CEO Robert Leasure on Q2 2021 Results - Earnings Call Transcript
11:13am, Saturday, 08'th May 2021
Inotiv, Inc. (NOTV) CEO Robert Leasure on Q2 2021 Results - Earnings Call Transcript
Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results
04:05pm, Wednesday, 05'th May 2021
WEST LAFAYETTE, Ind., May 05, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in non
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
03:40pm, Friday, 30'th Apr 2021
WEST LAFAYETTE, Ind., April 30, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in n
Inotiv, Inc. to Report Second Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, May 5, 2021
08:33am, Monday, 26'th Apr 2021
WEST LAFAYETTE, Ind., April 26, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares
11:15am, Friday, 23'rd Apr 2021
WEST LAFAYETTE, Ind., April 23, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in n
NOTV Stock: Over 15% Decrease Pre-Market Explanation
08:13am, Wednesday, 21'st Apr 2021
The stock price of Inotiv, Inc. (NASDAQ: NOTV) fell by over 15% pre-market. This is why it happened.
Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares
06:05am, Wednesday, 21'st Apr 2021
WEST LAFAYETTE, Ind., April 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in n
Inotiv, Inc. Announces Proposed Public Offering of Common Shares
05:16pm, Tuesday, 20'th Apr 2021
WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in n
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021
05:12pm, Tuesday, 20'th Apr 2021
WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in n
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
08:33am, Friday, 16'th Apr 2021
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of non-clinical and analytical contract
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
04:35pm, Tuesday, 13'th Apr 2021
WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading provider of nonclinical and analytical contract
